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ABSTRACT: Here we characterize the [Fe4S4] cluster nitrosylation of a DNA repair enzyme, Endonuclease III (EndoIII), using DNA-
modified gold electrochemistry and protein film voltammetry, electrophoretic mobility shift assays, mass spectrometry of whole and trypsin-
digested protein, and a variety of spectroscopies. Exposure of EndoIII to nitric oxide under anaerobic conditions transforms the [Fe4S4] clus-
ter into a dinitrosyl iron complex, [(Cys)2Fe(NO)2]–, and Roussin’s red ester, [(µ-Cys)2Fe2(NO)4], in a 1:1 ratio with an average retention of 
3.05 ± 0.01 Fe per nitrosylated cluster. The formation of the dinitrosyl iron complex is consistent with previous reports, but the Roussin’s red 
ester is an unreported product of EndoIII nitrosylation. Hyperfine sublevel correlation (HYSCORE) pulse EPR spectroscopy detects two 
distinct classes of NO with 14N hyperfine couplings consistent with the dinitrosyl iron complex and reduced Roussin’s red ester. Whole-
protein mass spectrometry of EndoIII nitrosylated with 14NO and 15NO support the assignment of a protein-bound [(µ-Cys)2Fe2(NO)4] 
Roussin’s red ester. The [Fe4S4]2+/3+ redox couple of DNA-bound EndoIII is observable using DNA-modified gold electrochemistry, but ni-
trosylated EndoIII does not display observable redox activity using DNA electrochemistry on gold despite having a similar DNA-binding 
affinity as the native protein. However, direct electrochemistry of protein films on graphite reveals the reduction potential of native and nitro-
sylated EndoIII to be 127 ± 6 and –674 ± 8 mV vs NHE, respectively, corresponding to a shift of approximately –800 mV with cluster nitro-
sylation. Collectively, these data demonstrate that DNA-bound redox activity, and by extension DNA-mediated charge transport, is modulat-
ed by [Fe4S4] cluster nitrosylation.  
INTRODUCTION 
Nitric oxide (NO) is an endogenous reactive nitrogen species 
that plays an important role in homeostatic regulation,1–3 cytopro-
tective and cytotoxic pathways,4–6 tumor progression,7–10 and bio-
film dispersal.11 NO often elicits a response by coordinating metal 
centers of metalloenzymes, such as in heme nitrosylation of soluble 
guanylyl cyclase during vasodilation.12 Non-heme Fe centers are 
also prone to nitrosylation. For example, the transcription factors 
SoxR, NsrR, and FNR each contain a [Fe2S2] or [Fe4S4] cluster that 
react with NO.13–17 The [Fe4S4] clusters in transcription factors 
often play a functional role by modulating protein conformation 
which, in turn, modulates DNA-binding affinity and gene expres-
sion.17 Nitrosylation of iron–sulfur clusters typically results in pro-
tein-bound iron nitrosyl species such as the relatively common 
dinitrosyl iron complex, [(Cys)2Fe(NO)2]–.18–20 However, there is 
growing evidence that other iron nitrosyl species, such as the Rous-
sin’s red ester, [(µ-Cys)2Fe2(NO)4], a structural analogue of the red 
iron nitrosyl salt reported by Roussin in 1858 (Figure 1),21 are more 
common than previously thought.22–26 While recent studies have 
focused on the nitrosylation of transcription factors, the [Fe4S4] 
clusters of DNA repair enzymes, such as Endonuclease III (En-
doIII) and DinG, are also targets for NO reactivity.27,28 
 
 
Figure 1. Structure of a protein-bound [Fe4S4]2+ cluster, dinitrosyl iron 
complex, Roussin’s red ester, and the Roussin’s red salt anion. 
The [Fe4S4] clusters in DNA repair enzymes were once thought 
to be strictly structural motifs based on their relatively positive 
reduction potential. However, upon binding DNA, the close prox-
imity of the polyanionic phosphate backbone negatively shifts the 
[Fe4S4]2+/3+ midpoint potential to approximately 80 mV vs normal 
hydrogen electrode (NHE) thereby activating its redox activity in 
the DNA-bound form.29–31 Our laboratory has proposed that redox 
signaling between DNA-bound [Fe4S4]2+ and [Fe4S4]3+ clusters, 
utilizing DNA-mediated charge transport (DNA CT), facilitates 
efficient DNA lesion detection.32 Given the importance of [Fe4S4] 
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clusters for DNA CT in biology and their propensity to react with 
NO, we are interested in studying how NO affects DNA CT by 
cluster nitrosylation.  
Our laboratory has explored DNA CT using EndoIII in Esche-
richia coli as a model [Fe4S4] cluster DNA repair enzyme. The 
[Fe4S4] cluster of EndoIII reacts with NO, leading to inactivation of 
DNA repair.27 However, [Fe4S4] cluster nitrosylation of EndoIII has 
not been explored within the context of DNA CT. Here we report 
the effect of EndoIII [Fe4S4] cluster nitrosylation on DNA CT 
using DNA-modified gold electrochemistry, protein film voltam-
metry, electrophoretic mobility shift assays, mass spectrometry of 
whole and trypsin-digested protein, and UV–vis, continuous-wave 
(CW) and pulse electron paramagnetic resonance (EPR), and 
circular dichroism spectroscopies. We connect our biophysical 
observations within the DNA CT model to account for the electro-
chemical consequences of [Fe4S4] cluster nitrosylation. 
 
EXPERIMENTAL SECTION 
General Procedures. All chemicals were of reagent-grade purity 
or better, purchased from Sigma Aldrich unless otherwise noted, 
and used as received unless otherwise noted. Water was purified on 
a Milli-Q Reference Ultrapure Water Purification System (≥18.2 
MΩ cm). Anaerobic atmospheres (3–4% H2 in N2, ≤1 ppm O2) 
were maintained in vinyl chambers using Pd scrubbing towers 
(Coy Laboratories).  
EndoIII Overexpression and Purification. Following reported 
procedures,30 E. coli EndoIII was overexpressed in BL21star-
(DE3)pLysS cells containing a pET11-His6-ubiquitin-nth con-
struct. Purification was performed at 4 °C using fast protein liquid 
chromatography (Bio-Rad). Protein was kept in storage buffer (20 
mM phosphates, 150 mM NaCl, 0.5 mM EDTA, 10% v/v glycerol, 
pH 7.5) at –80 °C until further use. Purity of isolated EndoIII was 
≥95% as determined by SDS-PAGE. EndoIII concentrations were 
determined by UV–vis using peptide and [Fe4S4] cluster absorb-
ances at 280 (ε = 19.94 × 103 M–1 cm–1 as calculated by ExPASy 
ProtParam, Swiss Institute of Bioinformatics) and 410 nm (ε = 17.0 
× 103 M–1 cm–1),33 respectively. 
EndoIII Nitrosylation with Natural Abundance NO. NO was in-
troduced to reaction solutions through the proton-mediated de-
composition of 1-(hydroxy-NNO-azoxy)-L-proline, disodium salt 
(PROLI NONOate, Cayman Chemicals). PROLI NONOate (~10 
mg aliquot in vial) was dissolved in 400 µL of a solution of Ar-
sparged NaOH (0.01 M), quantified by UV–vis absorbance at 252 
nm  (ε = 8.40 × 103 M–1 cm–1),34 and stored on ice under an anaero-
bic atmosphere until further use.  EndoIII nitrosylation reactions 
were prepared by bringing an aliquot of EndoIII (100 µM in stor-
age buffer) on ice into the anaerobic chamber. Within the anaero-
bic chamber, PROLI NONOate (typically 80–85 mM in 0.01 M 
NaOH) was added directly to Ar-sparged storage buffer (pH 7.5) 
to initiate the decomposition of PROLI NONOate (3.75 mM), 
which was vortexed and used within 5 min of preparation. PROLI 
NONOate in buffer was mixed with an appropriate volume of stor-
age buffer and EndoIII to achieve a 1:50 EndoIII/NO ratio (1 
equivalent of PROLI NONOate decomposes to 2 equivalents of 
NO). The final concentration of EndoIII was 60 µM during nitro-
sylation in a total reaction volume of 83 µL. After 10 min and still 
within the anaerobic chamber, the nitrosylation reaction solution 
was loaded onto a pre-rinsed Micro Bio-Spin 6 size-exclusion col-
umn (Bio-Rad) and spun into a clean 1.5 mL tube following the 
manufacturer’s protocol. For every nitrosylation reaction, a non-
NO-exposed control was included and also purified by a size-
exclusion column. Experiments and successive dilutions or concen-
trations were performed using filtrate collected after size-exclusion 
purification.  
UV–Vis, Circular Dichroism, and CW EPR Spectroscopies. UV–
vis data were acquired using either a Cary 100 Bio (Agilent) or 
DeNovix DS-C spectrophotometer. Circular dichroism spectros-
copy was performed using an AVIV Biomedical spectrometer in the 
Beckman Institute Laser Resource Center. In an anaerobic cham-
ber, protein collected from size-exclusion purification was diluted 
to 10 µM in a total volume of 800 µL and loaded into rectangular 
spectrophotometer cells with 2 mm pathlength (Starna Cells). 
Spectra are normalized to ellipticity minima at 222 nm.  
X-band CW-EPR spectroscopy was performed on an EMX X-
band spectrometer (Bruker) equipped with an ESR-900 cryogen 
flow cryostat (Oxford) and an ITC-503 temperature controller.  
Samples (150 µL each) were loaded into 4 mm thin-wall precision 
quartz EPR tubes (Wilmad LabGlass, 715-PW-250MM). To re-
duce dinitrosyl iron and Roussin’s red complexes, nitrosylated En-
doIII was incubated with sodium dithionite (1:25 pro-
tein/dithionite ratio) for 30 min prior to freezing in liquid nitrogen 
while remaining capped under an anaerobic atmosphere. An acqui-
sition temperature of 60 K and microwave power of 0.204 mW 
were used for the ratiometric comparison of double integration 
spin intensities because the iron nitrosyl signals were not saturated 
under these conditions. Signal saturation was evaluated by ensuring 
signal intensity grew as the square root of microwave power. Dou-
ble integration spin intensities were measured using Matlab 
R2016a. 
Synthesis of 15NO and Quantification with Deoxymyoglobin. To 
a 10 mL conical tube was added Na15NO2 (400 mg, 5.72 mmol, 98 
atom % 15N) and FeSO4·7H2O (2. 00 g, 7.19 mmol). The tube was 
capped with a rubber septum and charged with Ar. The dropwise 
addition of concentrated H2SO4 (4 mL) into the capped reaction 
vessel produced heat and vigorous gas evolution which was di-
rected by cannula from the reaction vessel into the bottom of a 
NaOH scrubbing tower (10 mL, 1 M). Gases from the headspace 
of the scrubbing tower were further directed by a separate cannula 
and bubbled into a 4 mL glass vial containing 2 mL of ice-cold de-
gassed buffer (20 mM phosphates, 150 mM NaCl, 0.5 mM EDTA, 
10% v/v glycerol, pH 7.5). At the time of bubbling, the glass vial 
was capped with a rubber septum and a needle was used as a vent to 
relieve pressure in the system. After gas evolution from the reaction 
vessel had ceased (2–3 min of gas bubbling), the glass vial with 
buffer was brought into an anaerobic chamber remaining capped 
and on ice. The concentration of 15NO in the buffer was deter-
mined under an anaerobic atmosphere using a deoxymyoglobin 
colorimetric method.  
The method for determining the concentration of dissolved NO 
in buffer is adapted from a reported procedure.35 Equine heart 
metmyoglobin (27 mg, 1.53 µmol) was dissolved in 500 µL buffer 
(20 mM phosphates, 150 mM NaCl, 0.5 mM EDTA, 10% v/v glyc-
erol, pH 7.5) and reduced to deoxymyoglobin using sodium dithi-
onite (7.6 mg, 43.7 µmol) under an anaerobic atmosphere. Excess 
sodium dithionite was removed by size-exclusion purification using 
Micro Bio-Spin 6 size-exclusion columns (Bio-Rad). The reduction 
of metmyoglobin to deoxymyoglobin is evidenced by a shift in the 
Soret band from 418 nm for metmyoglobin to 434 nm for deox-
ymyoglobin. The UV–vis spectrum of deoxymyoglobin indicates 
no observable contamination by oxymyoglobin (418, 542, and 580 
nm) or metmyoglobin (408, 502, and 630 nm). The concentration 
of deoxymyoglobin was 3.62 mM determined using a reported 
extinction coefficient of 114 mM–1 cm–1 at 434 nm.35,36 
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Deoxymyoglobin was used to quantify the concentration of 
15NO dissolved in buffer by a ratiometric comparison with 14NO. 
PROLI NONOate was used to prepare a solution of 14NO with 
excess deoxymyoglobin (14NO/deoxymyoglobin ratio of 1:1.3). A 
separate solution was prepared at the same time containing an ali-
quot of 15NO solution added to the same quantity of deoxymyoglo-
bin used for the 14NO standard. After 1 h of equilibration under an 
anaerobic atmosphere, UV–vis absorbances at 420 nm were used to 
calculate the concentration of the 15NO solution based on the 
known concentration of 14NO using eq 1. 
 
[15NO] = (15NOA420/14NOA420)[14NO]  (1) 
 
EndoIII Nitrosylation with 15NO. A 33.3 µL aliquot of 15NO (2.7 
mM) in ice-cold buffer was added to EndoIII under an anaerobic 
atmosphere. After 10 min, the reaction solution was purified by 
size-exclusion purification on pre-rinsed Micro Bio-Spin 6 size-
exclusion columns (Bio-Rad). Experiments and successive dilu-
tions or concentrations were performed using filtrate collected after 
size-exclusion purification.   
Pulse EPR. Samples for hyperfine sublevel correlation 
(HYSCORE) EPR spectroscopy were prepared by concentrating 
nitrosylated EndoIII samples with or without dithionite treatment 
using Amicon Ultra Centrifugal Filters (10k molecular weight cut 
off) to a concentration of 0.5 mM protein in 75 µL. 
All pulse X-band (9.7 GHz) and Q-band (34 GHz) EPR and 
HYSCORE spectroscopy was performed using a Bruker ELEXSYS 
E580 pulse EPR spectrometer equipped with a Bruker MD4 (X-
band) or D2 (Q-band) resonator. Temperature control was 
achieved using an ER 4118HV-CF5-L Flexline Cryogen-Free VT 
cryostat manufactured by ColdEdge equipped with an Oxford In-
struments Mercury ITC temperature controller. 
Pulse X- and Q-band HYSCORE spectra were acquired using 
the 4-pulse sequence (π/2 – τ – π/2 – t1 – π – t2 – π/2 – τ – echo), 
where 𝜏 is a fixed delay, and t1 and t2 are variable delays inde-
pendently incremented by Δt1 and Δt2, respectively. Sixteen step 
phase cycling was utilized to eliminate contributions from second-
ary/tertiary echoes. The time domain spectra were baseline-
corrected (third-order polynomial), apodized with a Hamming 
window function, zero-filled to eight-fold points, and fast Fourier-
transformed to yield the frequency domain. 
All EPR spectra (CW, HYSCORE) were simulated using the 
EasySpin37 simulation toolbox (version 5.2.16) with Matlab 2016b 
(see SI for description of simulations). 
Ferene Assay for Fe Quantitation. The ferene assay was per-
formed according to a published protocol.38 Briefly, samples were 
diluted 1:1 with HNO3 (21.7% v/v) to a total volume of 200 µL. 
Samples were heated at 95 °C for 30 min, cooled at 4 °C for 10 min, 
and centrifuged. To each sample was added 600 µL of ammonium 
acetate (7.5% w/v), 100 µL of ascorbic acid (12.5% w/v), and 100 
µL of 3-(2-pyridyl)-5,6-di(2-furyl)-1,2,4-triazine-5’,5’’-disulfonate 
(ferene, 10 mM). Samples were incubated under ambient condi-
tions for 30 min before absorbance at 593 nm was recorded. Cali-
bration curves were prepared using Fe standard solution (1001 ± 2 
mg/L Fe in 2% v/v HNO3, TraceCERT Fe standard for ICP). 
Protein Mass Spectrometry. Whole protein was analyzed using 
an Agilent 1100 series liquid chromatography mass selective detec-
tor (LC/MSD) system. Following size-exclusion purification, con-
trol and nitrosylated protein samples were diluted 1:50 or 1:20 in 
formic acid (0.2% v/v), respectively. Trypsin-digested protein 
samples were prepared by adding 5 µL of protein solution (60 µM) 
to 45 µL of sodium deoxycholate (1% w/v) in Tris buffer (100 
mM, pH 8.5). Disulfides were reduced by adding 0.5 µL of tris(2-
carboxyethyl)phosphine (TCEP, 0.5 M in water) and, after 20 min, 
protected by adding 1 µL of iodoacetamide (0.5 M in water) fol-
lowed by 20 min incubation in the dark under ambient conditions. 
To preserve disulfide bonds in some samples, TCEP was omitted 
from the digestion protocol. After thiol protection, 1 µL of lysyl 
endopeptidase (0.1 µg/µL in 100 mM Tris buffer, pH 8.5) was 
added to protein samples. After incubating for 2.5 h under ambient, 
dark conditions, all samples were diluted by half with the addition 
of Tris buffer (100 mM, pH 8.5) followed by the addition of 1 µL 
CaCl2 (100 mM in water) and 1 µL trypsin (0.44 µg/µL in 100 mM 
Tris buffer, pH 8.5). After digesting overnight at 37 °C, samples 
received formic acid (5% v/v) to bring the total sample volume to 
95 µL and produce a cloudy, white precipitate which was removed 
by centrifugation. Purification of the supernatant was performed by 
reverse-phase high performance liquid chromatography (HPLC), 
and solvent removed from purified samples by vacuum centrifuga-
tion. Dried samples were dissolved in formic acid (0.2% v/v) and 
were injected onto a capillary in-house packed C18 column and 
subjected to a 60 minute gradient by an Easy nLC 1200 HPLC. 
Chromatographically separated peptides were analyzed using a Q 
Exactive mass spectrometer (ThermoScientific) coupled to a 
NanoFlex ion source. 
Synthesis and Characterization of Thiol-Modified DNA. All oli-
gonucleotides were purified by reverse-phase HPLC using a C-18 
column (Agilent). Disulfide-modified oligonucleotide was synthe-
sized on a 3400 Applied Biosystems DNA synthesizer using stand-
ard phosphoramidite chemistry (all phosphoramidites were pur-
chased from Glen Research), where the C6 S–S phosphoramidite 
was installed at the 5’ terminus. Disulfide-modified oligonucleotide 
was cleaved from the solid support, purified by HPLC, and reduced 
to hexanethiol-modified oligonucleotide (5’ HS-C6-GTG CTG 
CAA CGT GTC TGC GC 3’) with dithiothreitol in buffer (50 mM 
Tris, 50 mM NaCl, pH 8.4). Thiol-modified oligonucleotide was 
purified by size-exclusion chromatography (GE Illustra NAP-5 
column), HPLC, and characterized by matrix-assisted laser desorp-
tion ionization time-of-flight mass spectrometry (MALDI–TOF, 
Bruker Autoflex); MALDI–TOF (m/z): [M+H]+ calculated for 
C200H264N73O124P20S, 6323.1; found, 6323.2. The complementary 
strand (5’ GCG CAG ACA CGT TGC AC 3’) was purchased from 
IDT and purified by HPLC. Oligonucleotides were further purified 
after HPLC by ethanol precipitation. Thiol-modified oligonucleo-
tide was annealed to its complement (50 µM oligonucleotides in 
Ar-sparged buffer containing 5 mM sodium phosphates, 50 mM 
NaCl, pH 7.0) by heating at 90 °C for 5 min followed by cooling to 
ambient temperature over 90 min. Thiol-modified double-stranded 
DNA was stored under Ar at –20 °C until further use. 
DNA-Modified Gold Electrochemistry. The fabrication of mul-
tiplexed gold chips has been previously described.39,40 Multiplexed 
gold chips were cleaned in acetone and isopropanol with soni-
cation, dried under an Ar stream, and ozone-cleaned for 25 min 
(UVO Cleaner). Immediately after cleaning, a rubber gasket (Bu-
na-N) and acrylic clamp were affixed to the chip surface, and thiol-
modified dsDNA (20 µL, 50 µM) was added to each quadrant to 
form a self-assembled monolayer on the gold electrode surface. 
After incubation with thiol-modified DNA for 18–21 h, quadrants 
were washed with buffer (5 mM sodium phosphates, 50 mM NaCl, 
pH 7.0) and incubated with 6-mercaptohexanol (1 mM in 5 mM 
sodium phosphates, 50 mM NaCl, pH 7.0). After 45 min, the elec-
trode was washed three times with Ar-sparged storage buffer and 
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brought into the anaerobic chamber for electrochemical analyses. A 
three-electrode setup was employed consisting of DNA-modified 
gold working electrodes, Ag/AgCl reference electrode (MW-2030, 
RE-6, BASi) with a gel tip (1.0% UltraPure Invitrogen Agarose 
prepared with 3 M NaCl), and a Pt wire auxiliary electrode. The 
total volume on the multiplexed chip was 200 µL. A scan rate of 100 
mV/s was used for cyclic voltammograms and potentials were con-
verted to the NHE scale. 
Direct Electrochemistry on Edge-Plane Graphite. Protein films 
were prepared on an edge-plane pyrolytic graphite electrode (Pine 
Research Instrumentation). Prior to protein deposition, the elec-
trode was cleaned by abrasion on sandpaper (400 grit) followed by 
sonication in isopropanol then water. Clean surfaces were con-
firmed by performing electrochemical experiments with protein 
storage buffer that did not contain glycerol. Micro Bio-Spin (Bio-
Rad) columns were used to exchange sample buffer with protein 
storage buffer that did not contain glycerol to enable dry film for-
mation. Protein films were deposited onto the electrode surface 
under an anaerobic atmosphere by sequential drying of protein 
aliquots (3 × 25 µL). Drying was accomplished by placing the up-
right electrode with aliquot in the airstream of a Pd catalyst fan box 
equipped with a single catalyst pack (Coy Laboratories) for approx-
imately 20 min per aliquot. Dried protein films were secured with 
10 µL Nafion (5% aqueous dispersion) to prevent film dispersal as 
previously described.41 After protein and Nafion depositions, a 
droplet (50 µL) of protein storage buffer without glycerol was add-
ed on top of the film. A three-electrode setup was employed by 
submerging reference and auxiliary electrodes in the droplet. The 
reference and auxiliary electrodes were the same used for DNA-
modified gold electrochemistry experiments described above. All 
potentials were converted to the NHE scale. 
Electrophoretic Mobility Shift Assays. A non-thiol-
functionalized analogue of the oligonucleotide used for DNA-
modified electrochemistry (5’ GTG CTG CAA CGT GTC TGC 
GC 3’) was purchased from IDT, purified by HPLC and ethanol 
precipitation, and radiolabeled through 5’ phosphorylation using 
[γ-32P] ATP (NEG035C005MC, 6000 Ci/mmol, 150 mCi/mL, 
Perkin Elmer) and T4 polynucleotide kinase (New England Bi-
oLabs) at 37 °C for 30 min followed by heat inactivation at 65 °C 
for 20 min. Purification of 32P-labeled oligonucleotide was accom-
plished by size-exclusion purification through a Micro Bio-Spin 6 
column (Bio-Rad) followed by a Monarch PCR & DNA Cleanup 
Kit (New England BioLabs) with a modified protocol. Briefly, to 50 
µL of filtrate from size exclusion was added 100 µL Monarch DNA 
Cleanup Binding Buffer and 300 µL ethanol. The resulting solution 
was loaded into a Monarch DNA Cleanup Column and spun at 
16,000 × g for 1 min. After discarding the flow-through, 500 µL of a 
1:4 solution of Monarch DNA Cleanup Binding Buffer and ethanol 
was added to the column and spun at 16,000 × g for 1 min. This 
washing procedure was repeated once more and flow-through dis-
carded each time. The column was spun at 16,000 × g for 1 min to 
remove residual ethanol, transferred to a clean 1.5 mL tube, and 25 
µL of Monarch Elution Buffer was carefully added to the center of 
the column matrix. After 1 min, the column was spun at 16,000 × g 
for 1 min to collect the purified, radiolabeled oligonucleotide, 
which was then annealed to its non-radiolabeled complement (10 
µM oligonucleotides in buffer containing 5 mM sodium phos-
phates, 50 mM NaCl, pH 7.0) by heating at 90 °C for 10 min fol-
lowed by cooling to ambient temperature over 3 h. Complete an-
nealing was verified by native 10% polyacrylamide gel electropho-
resis at 4 °C (50 V, 0.5× Tris/borate/EDTA buffer) using single-
stranded controls. Gels were imaged by dark exposure to BAS stor-
age phosphor screens followed by imaging on a Typhoon FLA 
9000 Imager (GE Healthcare Life Sciences). Radiolabeled dsDNA 
was incubated with native or nitrosylated EndoIII for 1 h at 4 °C 
prior to native 10% polyacrylamide gel electrophoresis at 4 °C (50 
V for 3 h in 1× TGX buffer). Gel exposure time was calculated the 
radioactivity of a 10 µL aliquot where a scintillation reading of 
300,000 counts per minute corresponded to 1 h exposure on stor-
age phosphor screens. Free dsDNA band intensity was measured 
using ImageQuant 5.2, and normalized band intensities were used 
to calculate dissociation constants by the Hill function in OriginPro 
2017. 
 
RESULTS AND DISCUSSION 
Characterization of Nitrosylated EndoIII by UV–vis Spectros-
copy and the Ferene Assay. We sought to characterize the products 
of EndoIII nitrosylation to enable a rational interpretation of our 
biophysical observations. At the outset of our work, the reaction 
between NO and the [Fe4S4]2+ cluster of EndoIII was reported with 
a focus on the titration of EndoIII with NO, enzyme activity, and 
the reversibility of [Fe4S4]2+ cluster nitrosylation.27  Additionally, 
the dinitrosyl iron complex, [(Cys)2Fe(NO)2]–, was the only pro-
tein-bound iron nitrosyl species observed.27  In the absorbance 
spectrum of native EndoIII, we observe absorbances at 280 and 410 
nm consistent with the presence of a protein-bound [Fe4S4]2+ clus-
ter.33 The [Fe4S4]2+ cluster of native EndoIII is relatively stable to 
handling in air, but NO degrades the cluster within a 10 min reac-
tion period. The absorbance spectrum of nitrosylated EndoIII is 
similar to native EndoIII at 280 nm but differs at longer wave-
lengths primarily through a 46 nm hypsochromic shift of the cluster 
absorbance maximum to a new feature at 364 nm (Figure 2). This 
nitrosylation reaction proceeds similarly in the presence of excess 
dsDNA (EndoIII/dsDNA ratio of 1:10) as evidenced by a nearly 
identical UV–vis absorbance spectrum (Figure S1). The new ab-
sorbance centered at 364 nm is consistent with a Roussin’s red 
ester, [(µ-Cys)2Fe2(NO)4], which exhibits a highly conserved ab-
sorbance maximum in the 360 ± 10 nm range in proteins, peptides, 
and synthetic model complexes.22,24,42–45  
Additional support for the presence of a multinuclear iron nitro-
syl complex stems from ferene colorimetric assays, which were used 
to quantify protein-bound Fe of native and nitrosylated EndoIII. 
The concentration of protein-bound [Fe4S4] cluster was deter-
mined using the reported extinction coefficient of 17.0 × 103 M–1 
cm–1 at 410 nm,33 and the concentration of Fe per cluster was 
measured using the ferene colorimetric assay where ferene-chelated 
Fe(II) is detected at 593 nm (Figure 2). Native EndoIII was found 
to contain 4.00 ± 0.09 Fe per cluster, and this value decreased to 
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Figure 2. Spectroscopic characterization of EndoIII [Fe4S4] cluster nitrosylation. (Top)  Representation of the conversion of native EndoIII 
into nitrosylated EndoIII by a 10 min exposure to NO (50 equiv). (Bottom left) UV–vis spectra of native (black) and nitrosylated (red) En-
doIII revealing a 46 nm hypsochromic shift (inset). (Bottom middle) Representative results of the ferene colorimetric assay for native En-
doIII (black), nitrosylated EndoIII (red), and a buffer blank (dotted line). Native EndoIII contains 4.00 ± 0.09 Fe per cluster, and this value 
decreased to 3.05 ± 0.01 Fe for nitrosylated EndoIII. (Bottom right) CW EPR spectra of nitrosylated EndoIII before (red) and after (blue) a 
30 min treatment with sodium dithionite (25 equiv) recorded at 60 K, microwave frequency of 9.3701 GHz, and microwave power of 0.204 
mW. All experiments were performed in the absence of DNA and buffer was pH 7.5 and contained 20 mM phosphates, 150 mM NaCl, 0.5 
mM EDTA, and 10% v/v glycerol. 
 
3.05 ± 0.01 Fe for nitrosylated EndoIII prepared from a 10 min 
exposure to NO. If [(Cys)2Fe(NO)2]– is the only iron nitrosyl spe-
cies to form in the tetracysteine cluster-binding pocket, then nitro-
sylated EndoIII should retain only 1 or 2 Fe per nitrosylated clus-
ter. Accordingly, the retention of 3 Fe per nitrosylated cluster 
strongly indicates that an iron nitrosyl species with more than 1 
equivalent of Fe is present, which is likely the [(µ-Cys)2Fe2(NO)4] 
Roussin’s red ester based on UV–vis observations described above. 
The retention of 3 Fe in nitrosylated EndoIII necessitates the re-
lease of 1 Fe equivalent in a labile form which is subsequently re-
moved from our reaction solutions by size-exclusion purification. 
The release of labile Fe upon reaction with NO is consistent with 
cluster degradation.17 
Characterization of Nitrosylated EndoIII by CW EPR Spectros-
copy. To gain further insight into the products of EndoIII nitrosyla-
tion, we performed CW and pulse EPR experiments using native 
and nitrosylated EndoIII in the absence of DNA. The CW EPR 
spectrum of native EndoIII is devoid of signal and consistent with a 
diamagnetic sample (Figure S2), while the corresponding spectrum 
of nitrosylated EndoIII contains a slightly rhombic signal with g = 
[2.042, 2.036, 2.015], consistent with a mononuclear 
[(Cys)2Fe(NO)2]– dinitrosyl iron complex (Figure 2).22,42 
When nitrosylated EndoIII is treated with sodium dithionite 
(protein/dithionite ratio of 1:25), a new axial signal with g⊥ = 2.011 
and g∥ = 1.972 emerges consistent with the binuclear [(µ-
Cys)2Fe2(NO)4]– complex referred to as the reduced Roussin’s red 
ester.22,42 A ratiometric comparison of the double-integration spin 
intensities indicates that [(Cys)2Fe(NO)2]– and [(µ-
Cys)2Fe2(NO)4]– form in a 1:1 ratio (see Figures S3 and S4 for 
comparison of single-integration signals and simulations of CW 
EPR spectra, respectively). 
To simplify electron counting and avoid assigning formal oxida-
tion states in iron nitrosyl complexes, the Enemark-Feltham nota-
tion, {M(NO)x}n, is used where M is the metal center, x is the 
number of metal-bound nitrosyl ligands, and n is the total number 
of electrons in the metal d and NO π* orbitals.46 The CW EPR 
spectrum of native EndoIII is devoid of any observable signal, con-
sistent with a diamagnetic [Fe4S4]2+ cluster,47 while nitrosylated 
EndoIII exhibits a rhombic signal centered at g = 2.029 consistent 
with the presence of an {Fe(NO)2}9 dinitrosyl iron complex.22,42 
Interestingly, when nitrosylated EndoIII is reduced with dithionite, 
the {Fe(NO)2}9 profile diminishes and a new axial signal is ob-
served with g⊥ = 2.011 and g∥ = 1.972. The {Fe(NO)2}9 dinitrosyl 
iron complex is the only species observed by EPR directly after 
cluster nitrosylation because it is the only paramagnetic (S = 1/2) 
species initially formed, while the {Fe(NO)2}9–{Fe(NO)2}9 Rous-
sin’s red ester, a dimerized analogue of the dinitrosyl iron complex, 
contains two antiferromagnetically coupled Fe centers and is there-
fore EPR silent as synthesized. Upon reduction by dithionite, the 
{Fe(NO)2}9 dinitrosyl iron complex is reduced into an EPR-silent 
{Fe(NO)2}10 complex, while the EPR-silent {Fe(NO)2}9–
{Fe(NO)2}9 Roussin’s red ester is reduced into the EPR-active 
{Fe(NO)2}9–{Fe(NO)2}10 (S = 1/2) species referred to as the 
reduced Roussin’s red ester (Scheme 1). 22,43 Our assignment of the 
reduced Roussin’s red ester, [(µ-Cys)2Fe2(NO)4]–, is supported by 
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similar EPR resonances observed for synthetic and peptide-bound 
model complexes.23,42,48  
It should be noted that the reduced Roussin’s red ester signal 
with principle g-values of g⊥ = 2.011 and g∥ = 1.972 was originally 
assigned as a d9 dinitrosyl iron complex having been reduced from a 
d7 form.19 However, compelling spectroscopic data of structurally 
well-characterized model complexes disagree with the initial as-
signment and instead support the assignment of a reduced Rous-
sin’s red ester.42,45 The spectroscopic agreement between reduced 
Roussin’s red ester model complexes and other protein-bound iron 
nitrosyl species, once considered d9 dinitrosyl iron complexes, has 
been noted previously.23 It therefore appears the protein-bound 
Roussin’s red ester, once overlooked due to its EPR-silent nature in 
the neutral form, is indeed more common than previously 
thought.22–26 
Collectively, these CW EPR data support the observation that 
nitrosylated EndoIII contains both the dinitrosyl iron complex and 
Roussin’s red ester. The reason that the Roussin’s red ester has not 
been explicitly reported for EndoIII is likely because it is EPR si-
lent. To measure the ratio of dinitrosyl iron complex to reduced 
Roussin’s red ester, the CW EPR signals were compared. The dou-
bly-integrated spectral intensities of {Fe(NO)2}9 and Fe(NO)2}9–
{Fe(NO)2}10 reveal they form in a 1:1 ratio, indicating EndoIII 
retains 1 Fe equivalent from [(Cys)2Fe(NO)2]– and 2 Fe equiva-
lents from [(µ-Cys)2Fe2(NO)4] for a total retention of 3 Fe per 
nitrosylated cluster. This observation is consistent with the ferene 
assay results where nitrosylated EndoIII retains an average of 3.05 
± 0.01 Fe per nitrosylated cluster. Considering the [Fe4S4]2+ cluster 
is bound by four cysteine residues, and that dinitrosyl iron complex 
and Roussin’s red ester each require only two cysteine residues, it is 
likely that the cysteine residues originally bound to the [Fe4S4]2+ 
cluster are responsible for binding the iron nitrosyl species after 
nitrosylation. 
 
Scheme 1. Cluster nitrosylation followed by reduction by dithionite 
as visualized through conversions between EPR-active and EPR-
silent states. 
 
 
Characterization of Nitrosylated EndoIII by Pulse-EPR Spec-
troscopy with 14/15NO. To gain further insight into the electronic 
structure of protein-bound iron nitrosyl complexes through meas-
urement of the nitrosyl 14/15N hyperfine interactions, we performed 
pulse EPR experiments. Initial characterization by X-band 
HYSCORE spectroscopy of [(Cys)2Fe(NO)2]– and [(µ-
Cys)2Fe2(NO)4]– prepared using natural abundance (14N = 
99.63%) NO reveal features consistent with two distinct classes of 
hyperfine couplings from 14N nuclei of the nitrosyl ligands (Figure 
3), with one relatively weakly coupled 14N exhibiting signals in the 
(+,+) quadrant and a more strongly coupled 14N exhibiting features 
in the (–,+) quadrant (Figure 3).  
In order to further confirm these assignments and constrain the 
hyperfine coupling and nuclear quadrupole interaction parameters 
independently, Q-band (34 GHz) HYSCORE spectroscopy was 
performed on samples generated with isotopically enriched 15N (I = 
1/2), generated from 15NO2– and quantified using deoxymyoglobin 
(see Figures S5 and S6 for representative UV–vis spectra), and 
natural abundance NO (Fig. 4).  The Q-band HYSCORE spectra 
of the 15NO isotopologues of both the of [(Cys)2Fe(NO)2]– and 
[(µ-Cys)2Fe2(NO)4]– differ markedly from their natural abundance 
variants, confirming that these features indeed arise from hyperfine 
couplings to the NO nitrogens. Elimination of nuclear quadrupole 
interactions in the 15NO samples allowed for the 15N hyperfine 
couplings to be determined via simulation (see Figures S7–S9 for 
Q-band HYSCORE spectra and simulations of 14N/15N hyperfine 
couplings). Accounting for the ratio of 15/14N nuclear g-values (15N 
gn/14N gn = -1.403), the 14N hyperfine couplings were then fixed 
(Table 1), and the nuclear quadrupole coupling constant (e2qQ/h) 
and electric field gradient asymmetry (η) determined for each 14N 
nucleus via simulation of the data.  
Simulations of the combined multifrequency HYSCORE data 
set for the EndoIII [(Cys)2Fe(NO)2]– dinitrosyl iron complex indi-
cate nitrogen hyperfine couplings to two distinct classes of NO, one 
more strongly coupled with 14N aiso = 13.3 MHz and the other 
much more weakly coupled with 14N aiso = 0.5 MHz. The non-
equivalence the two NO ligands is expected because dinitrosyl iron 
species exhibit two distinct NO stretching frequencies.35 This non-
equivalence is also predicted by density functional theory.49 These 
relatively small 14N hyperfine couplings are consistent with the 
assignment of an {Fe(NO)2}9 dinitrosyl iron complex with spin 
density largely localized on the Fe center as opposed to an 
{Fe(NO)}7 species, which exhibit much larger 14N hyperfine cou-
plings (aiso ≥ 30 MHz, up to 220 MHz) due to unpaired spin being 
primarily localized on the NO moiety.35  
Similarly, the multifrequency HYSCORE data set for the En-
doIII [(µ-Cys)2Fe2(NO)4]– reduced Roussin’s red ester also indi-
cate nitrogen hyperfine couplings to two distinct classes of NO, one 
more strongly coupled with 14N aiso = 5.5 MHz and the other more 
weakly coupled with 14N aiso = 2.7 MHz. Because this species con-
sists of a mixed-valence, antiferromagnetically coupled 
{Fe(NO)2}9–{Fe(NO)2}10 (S = 1/2) dimer, these two classes of 
NO 14N hyperfine couplings likely represent two non-equivalent 
NO ligands on the {Fe(NO)2}9 fragment (analogous to the dinitro-
syl iron complex) with no significant contribution from the NO 
ligands on the diamagnetic {Fe(NO)2}10 fragment.  
Collectively, the relatively low magnitude of the 14N nuclear 
quadrupole coupling constants observed for all of the NO nitro-
gens, e2qQ/h = 0.8-1.4 MHz combined with the low estimation for 
the electric field gradient asymmetry (η) indicate axial symmetry of 
charge about the NO nitrogen with significant population of charge 
density in the NO π orbitals orthogonal to the NO σ orbital, as 
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Figure 3. X-band HYSCORE spectra and simulations of 14N hyperfine couplings. (Top left) X-band HYSCORE spectrum of nitrosylated 
EndoIII acquired at 341.8 mT (g = 2.036) corresponding to the [(Cys)2Fe(NO)2]– dinitrosyl iron complex. (Bottom left) nitrosylated En-
doIII after treatment with dithionite acquired at 348.5 mT (g = 1.998) corresponding to the [(µ-Cys)2Fe2(NO)4]– reduced Roussin’s red 
ester. Left panels show the experimental spectra, with intensities indicated by colors ranging from blue to red in order of increasing intensity. 
The rightmost panels depict the experimental data in grey and overlay simulations from a relatively strongly coupled 14N nucleus (blue, de-
noted N1) and a relatively weakly coupled 14N nucleus (red, denoted N2). Specific simulation parameters are detailed in Table 1. Acquisition 
parameters: temperature = 20 K; microwave frequency = 9.740 GHz (a), 9.744 GHz (b); MW pulse lengths π/2, π = 8, 16 ns; τ = 138 ns (a), 
138 ns (b); t1 = t2 = 100 ns; Δt1 = Δt2 = 16 ns; shot repetition time (srt) = 1 ms. 
Table 1. Combined 14N hyperfine and nuclear quadrupole coupling parameters for EPR-active nitrosylated species observed in EndoIII.  
Species Nucleus A (MHz) aisoa (MHz) (α,β,γ)°HFC e2qQ/h (MHz) η (α,β,γ)°NQI 
[(Cys)2Fe(NO)2]– 
g = [2.042, 2.036, 2.015] 
14N1 [24, 6, 10] 13.3 (0, 0, 0) 1.4 >0.1 (0, 0, 0) 
14N2 [–2.2, –2.2, 6] 0.5 (0, –30, 0) 0.8 >0.1 (0, –30, 0) 
[(µ-Cys)2Fe2(NO)4]– 
g = [2.011, 2.010, 1.972] 
14N1 [2, 12.5, 2] 5.5 (0, 0, 0) 1.2 >0.2 (0, 0, 0) 
14N2 [–2.0, 4.5, 5.5] 2.7 (0, 0, 0) 1.0 >0.1 (0, 0, 0) 
a Isotropic hyperfine coupling constant, defined as aiso = (A1 + A2 + A3)/3. 
 
expected for the multiply-bonded NO moiety (see Table 1 for spe-
cific simulation parameters).   
In sum, these HYSCORE data further demonstrate that the di-
nitrosyl iron complex and Roussin’s red ester are both products of 
[Fe4S4]2+ cluster nitrosylation in EndoIII.  
Mass Spectrometry of Native and Nitrosylated EndoIII. Having 
identified and characterized iron nitrosyl complexes through UV–
vis and EPR spectroscopies, we turned to mass spectrometry for 
further characterization of protein-bound iron nitrosyl species. 
Whole protein was analyzed by diluting native and nitrosylated 
EndoIII in formic acid (0.2% v/v) followed by HPLC–MS. Native 
EndoIII has a lone mass at 33,264 Da corresponding to apoprotein 
where the cysteines originally binding the cluster are instead proto-
nated (Figure 4). This observation indicates the EndoIII [Fe4S4] is 
acid labile. Nitrosylated EndoIII yields multiple masses of relatively 
high abundance that provide insight into nitrosylation reaction 
products. First, masses at 33,260 and 33,292 Da correspond to 
apoprotein with two cysteine disulfides (2 Cys-SS-Cys) and apo-
protein with one cysteine disulfide and one cysteine trisulfide (Cys-
SS-Cys + Cys-SSS-Cys), respectively. Disulfide formation and the 
retention of cluster sulfides as polysulfides of cysteine are common 
features of [Fe4S4] cluster degradation by both NO and O2.17 In 
addition to apoprotein masses, we observe a mass at 33,494 Da 
corresponding to protein-bound [(µ-Cys)2Fe2(NO)4] present with 
a cysteine disulfide (33,264 – 2 + 232). To test whether the mass at 
33,494 Da arises from protein-bound [(µ-Cys)2Fe2(NO)4], we 
performed additional whole-protein mass spectrometry on nitro-
sylated EndoIII prepared using 15NO and observe a new mass at 
33,498 Da (Figure 4). This 4 Da mass shift is consistent with the 
substitution of four 14NO ligands for 15NO and therefore supports 
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the assignment of 33,494 Da as protein-bound [(µ-
Cys)2Fe2(NO)4]. The 15N-enriched sample displays a 4 Da mass 
shift because only the Roussin’s red ester is present in EndoIII after 
dilution in acid. This can be rationalized considering that the pKa of 
bridging cysteine thiolates of the Roussin’s red ester should be 
lower than the pKa of non-bridging thiolates of the dinitrosyl iron 
complex, rendering the dinitrosyl iron complex more acid labile 
than the Roussin’s red ester. These observations are similar to a 
recent report on the mass spectrometric detection of protein-
bound Roussin’s red ester of the transcription factor NsrR.50 
We next turned to mass spectrometry of trypsin-digested protein 
to test for specific off-target modifications to EndoIII caused by 
NO exposure. By itself, NO has selective reactivity for metal cen-
ters and thiols, but does not react directly with other amino acids. 
However, direct amino acid modification, commonly in the form of 
tyrosine nitration, can occur in the presence of NO2 formed from 
the reaction between NO and O2.51 For this reason, the nitrosyla-
tion reactions performed in this work were performed under anaer-
obic conditions. However, we still tested whether tyrosine nitration 
of EndoIII occurs specifically from NO treatment from the pres-
ence of residual O2 in reaction solutions. To test for tyrosine nitra-
tion specific to NO treatment, we digested native and nitrosylated 
EndoIII with trypsin and the resulting peptides were analyzed by 
electron transfer dissociation mass spectrometry. While we detect 
peptides modified by tyrosine nitration, the modification does not 
appear specific to NO exposure (Figure S10) thereby indicating 
minimal off-target effects. 
Figure 4. Deconvoluted mass spectra of (Left) native (black) and 
nitrosylated (red) EndoIII and (Right) nitrosylated EndoIII pre-
pared using 14NO (solid) and 15NO (dotted). 
 
Cluster Nitrosylation Abates DNA-Bound Redox Activity of En-
doIII. DNA-bound redox activity is a hallmark of DNA-processing 
proteins that participate in DNA CT. The DNA-bound redox activ-
ity of [Fe4S4] cluster proteins is typically evaluated using DNA-
modified gold electrodes, where the [Fe4S4]2+/3+ redox couple of the 
DNA-bound protein is observed near a midpoint potential of 80 
mV vs NHE.29–32 Because the current at 80 mV vs NHE reflects 
redox activity of the DNA-bound [Fe4S4] cluster protein, signal 
intensity at 80 mV vs NHE reflects the ability of a protein to partic-
ipate in DNA CT. We observe DNA-bound redox activity of native 
EndoIII at 80 mV vs NHE purified by size-exclusion filtration (Fig-
ure 5). However, no redox activity above the buffer background is 
observed on the same DNA-modified electrode for nitrosylated 
EndoIII purified by size-exclusion filtration.52 The absence of 
DNA-bound redox activity can be explained by either of the follow-
ing two factors: (1) the DNA-binding affinity of nitrosylated En-
doIII is lower than that of native EndoIII or (2) the reduction po-
tential of nitrosylated EndoIII is no longer at 80 mV vs NHE and is 
shifted out of the potential window for the DNA-modified gold 
electrode. In both of these scenarios, the redox activity at 80 mV vs 
NHE would decrease for nitrosylated EndoIII relative to the native 
enzyme. To examine these hypotheses in more detail, we turned to 
DNA-binding affinity measurements.  
Native and Nitrosylated EndoIII have Different Conformations 
but Similar DNA-Binding Affinities. One explanation for the lack of 
observable redox activity with nitrosylated EndoIII on DNA-
modified gold electrodes is that nitrosylated EndoIII binds DNA 
with a lower affinity than native EndoIII. We therefore examined 
changes to EndoIII DNA-binding affinity caused by [Fe4S4] cluster 
nitrosylation. To test if nitrosylated EndoIII has a lower DNA-
binding affinity than native EndoIII, we performed electrophoretic 
mobility shift assays. The assays were performed by incubating 
native and nitrosylated EndoIII with radiolabeled dsDNA followed 
by native gel electrophoresis. The percentage of EndoIII-bound 
dsDNA was visualized by phosphoimagery (see representative gels 
in Figure S11), quantified by measuring band intensities, and used 
to calculate dissociation constants with Hill function fitting (Figure 
5). Through these assays, native and nitrosylated EndoIII show 
similar DNA dissociation constants of 3.7 ± 0.4 and 2.2 ± 0.1 µM, 
respectively. If anything, the DNA affinity for the nitrosylated pro-
tein is higher, as would be expected given the more positive charge 
on the cluster site.31 Interestingly, circular dichroism spectra indi-
cate that [Fe4S4] cluster nitrosylation decreases the ε222/ε208 ellipti-
city ratio from 1.199 ± 0.005 to 0.90 ± 0.04 from native to nitrosyl-
ated EndoIII (Figure 5), which is consistent with disordering of 
alpha helices.53 Despite this disordering, [Fe4S4] cluster nitrosyla-
tion does not appear to lower the DNA-binding affinity. According-
ly, the absence of DNA-bound redox activity of nitrosylated En-
doIII cannot be explained by nitrosylated EndoIII having a signifi-
cantly lower DNA-binding affinity than native EndoIII. Since the 
DNA-binding affinity of nitrosylated EndoIII is not lower than 
native EndoIII, we suspected that the reduction potential of nitro-
sylated EndoIII is no longer at 80 mV vs NHE.  
Cluster Nitrosylation Shifts the EndoIII Reduction Potential by 
800 mV in the Negative Direction. Since redox activity of nitrosyl-
ated EndoIII is not observed on DNA-modified gold electrodes 
despite native and nitrosylated EndoIII having similar DNA-
binding affinities, we turned to direct electrochemistry experiments 
in the absence of DNA on a graphite electrode with a wider poten-
tial window. Using differential pulse voltammetry we observe a 
reduction potential of 127 ± 6 mV vs NHE in the voltammogram of 
native EndoIII (Figure 5). This value is consistent with previous 
measurements of EndoIII in the absence of DNA and is assigned as 
the [Fe4S4]2+/3+ reduction potential.41 However, the differential 
pulse voltammogram of nitrosylated EndoIII reveals a new reduc-
tive peak at –674 ± 8 mV vs NHE. The new reduction signal is 
specific to nitrosylated EndoIII and corresponds to an approxi-
mately 800 mV negative shift in reduction potential relative to na-
tive EndoIII. This shift places the reduction potential of nitrosylat-
ed EndoIII within a reasonable range to be reduced by dithionite 
(reduction potential range of –650 to –752 mV vs NHE from pH 
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Figure 5. Biophysical and electrochemical characterization of native and nitrosylated EndoIII. (Top left) Cyclic voltammograms of buffer 
(dotted), native EndoIII (black), and nitrosylated EndoIII (red) on a DNA-modified gold electrode. (Top middle) Results of electrophoretic 
mobility shift assays plotted as EndoIII-bound dsDNA as a function of EndoIII concentration.  Open circles and error bars represent the 
mean and standard error (n = 5), respectively. Solid lines represent Hill function fitting used to calculate dissociation constants. (Top right) 
Circular dichroism spectra of buffer (dotted), native EndoIII (black), and nitrosylated (red) EndoIII. (Bottom left) Differential pulse volt-
ammograms of background-subtracted native (black) and nitrosylated (red) EndoIII on an edge-plane graphite electrode. Samples used in 
circular dichroism and graphite electrochemistry experiments did not contain DNA. (Bottom right) Representation of a DNA-modified gold 
electrode surface with native EndoIII (left) and nitrosylated EndoIII (right). Small black lines represent mercaptohexanol used to passivate 
the gold electrode surface. DNA-bound redox activity is not observed for nitrosylated EndoIII despite having a similar DNA-binding affinity 
to native EndoIII. 
 
6.9–7.9)54 and also in the range of reduction potentials (–500 to –
1000 mV vs NHE) measured for dinitrosyl iron and Roussin’s red 
ester model complexes.55–59 We are unable to assign the reduction 
potential of –674 mV vs NHE to either iron nitrosyl species specifi-
cally. However, considering that by EPR we observe the reduction 
of both the dinitrosyl iron complex and Roussin’s red ester by di-
thionite, it is reasonable that the reductive wave at –674 mV vs 
NHE reflects the reduction of both iron nitrosyl species. Moreover, 
this reduction potential is outside the potential window of DNA-
modified gold electrodes; the thiolated DNA and mercaptohexanol 
monolayer is compromised when sweeping potentials below –300 
mV vs NHE (Figure S12). This shift in potential furthermore ex-
plains the lack of DNA-bound redox activity of nitrosylated En-
doIII despite having a similar DNA-binding affinity to native En-
doIII (Figure 5).  
EndoIII Nitrosylation and Implications for DNA CT and NO 
Signaling. Collectively, these data demonstrate that [Fe4S4] cluster 
nitrosylation of the bacterial DNA repair enzyme EndoIII results in 
two distinct protein-bound iron nitrosyl complexes, the dinitrosyl 
iron complex and Roussin’s red ester. The reaction of NO with 
EndoIII is similar in the absence and presence of DNA and leads to 
rapid and direct changes to the cluster with seemingly inconse-
quential changes in protein conformation. It is noteworthy that, 
despite this NO reactivity, the cluster in EndoIII is relatively stable 
to oxygen. 
Importantly, unlike native EndoIII with an intact [Fe4S4] cluster, 
nitrosylated EndoIII does not exhibit DNA-bound redox activity 
on DNA-modified gold electrodes. While there are conformational 
changes between native and nitrosylated EndoIII, nitrosylated 
EndoIII does not have a lower affinity for duplex DNA than native 
EndoIII. This observation is in contrast to NO-sensitive transcrip-
tion factors in which [Fe4S4] cluster nitrosylation modulates DNA-
binding affinity as a result of a conformational change. Instead of 
changes to DNA-binding affinity, we observe an 800 mV decrease 
in reduction potential between native and nitrosylated EndoIII 
using direct electrochemical measurements. It therefore appears 
that the primary consequence of EndoIII [Fe4S4] cluster nitrosyla-
tion is electrochemical in nature.  
The results of this study have critical implications in the DNA 
CT model based on two primary observations: (1) native and ni-
trosylated EndoIII bind dsDNA to a similar extent and (2) nitro-
sylated EndoIII is more difficult to reduce than native EndoIII by 
800 mV. These observations suggest that [Fe4S4] cluster nitrosyla-
tion might affect DNA CT between nitrosylated and native DNA 
repair enzymes. Moreover, we observe that the presence of excess 
dsDNA does not inhibit cluster nitrosylation under our reaction 
conditions indicating that both free and DNA-bound EndoIII are 
susceptible to NO. Within the context of NO signaling, this study 
expands the known bioinorganic effects of NO. In contrast to tran-
scription factor cluster nitrosylation for modulating DNA binding 
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and gene expression, we observe that [Fe4S4] cluster nitrosylation 
of a DNA repair enzyme results in a minimal change to DNA bind-
ing but a substantial modulation of redox activity.  
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